We are looking for a Medical Director (MD) to expand our Clinical Development team. Reporting to the Chief Medical Officer (CMO), the MD will lead clinical development activities for new drug candidates across multiple therapeutic areas and indications. The MD will assume a hands-on role in the design and oversight of clinical trials, in close partnership with Clinical Strategy and Operations, Regulatory Affairs, Pharmacovigilance, and Clinical Research Organizations (CROs).
What will you do?
- Contribute to the elaboration of clinical development plans for the company’s products, in keeping with the corporate strategy;
- Contribute to the development of product registration strategies and lead interactions with regulatory authorities;
- Design, author and develop clinical study protocols (Phases 1 to 3) from a concept sheet to a full protocol;
- Oversee and participate to protocol training, produce relevant training materials, and represent clinical development in Investigator meetings
- Contribute to study processes and deliverables and participate in development of informed consent forms (ICF), case report forms (CRF), safety management plans, medical monitoring plans, statistical analysis plans (SAP) and clinical study reports (CSR)
- Lead the development of clinical responses to protocol questions by healthy authorities, independent review boards and ethical committees, in collaboration with regulatory affairs and/or clinical operations;
- Review patient profiles, and study level data; review coding of adverse events (AEs), concomitant medications and protocol deviations;
- In close collaboration with clinical operations, data management, biometrics and CRO, participate in all reviews and procedures required for database lock;
- Review study data outputs to provide the most comprehensive clinical interpretation, for interim and final study reporting; develop topline study reports in collaboration with biometrics and relevant stakeholders (e.g., clinical pharmacology, translational sciences, etc.);
- Participate in the development and implementation of scientific communication and publication strategies for ongoing and completed studies;
- Support pharmacovigilance process; review individual data with Serious Adverse Events (SAEs) and important medical events; author and/or review all safety narratives and related regulatory reports (CIOMS, MedWatch);
- Support the timely execution of all clinical trials and the generation of high-quality clinical data according to predefined timelines and budget;
- Oversee the safety of subjects participating into clinical trials sponsored by the Company, and ensure full compliance with applicable rules and regulations overseeing pharmacovigilance;
- Provide medical and scientific expertise into Agomab’s Discovery and Preclinical Development programs;
- Identify and establish relationships with leading key opinion leaders (KOLs), including organizing and moderating KOL meetings and Advisory Boards;
- Contribute relevant sections of Investigational New Drug (IND) dossiers, Investigator’s Brochures (IB), DSURs and other regulatory documents.